Nanozymes catalyze enantioselective polymerization in cells, indicating potential for targeted cancer therapies.
Precise control over macromolecular chirality is critical for molecular recognition and targeted biological interventions. Herein, we report a pair of chiral gold nanozymes (l-/d-AuNEs) that mimic horseradish peroxidase (HRP)-like activity to catalyze the oxidative coupling of chiral phenolic monomers in a cellular environment. By introducing peptide ligands with both amino-acid-based configurational chirality and secondary structural chirality, the nanozymes enable high-yield enantioselective polymerization of the chiral Ritodrine (RITO), leading to the formation of enantiomeric dimers and high-molecular-weight polymers. The resulting polymers, Poly-l-RITO and Poly-d-RITO, exhibit significantly enhanced cytotoxicity relative to the monomer, with Poly-d-RITO showing a notably higher pro-apoptotic effect. Mechanistic studies reveal that Poly-d-RITO preferentially accumulates at the cell membrane and induces more severe membrane damage. These findings reveal a chirality-dependent biointerface effect and highlight the potential of nanozyme-driven asymmetric polymerization as an alternative strategy for chiral drug development and targeted cancer therapy.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: